psychiatric disease; behavioral disorder

From Aaushi
Jump to navigation Jump to search

Clinical manifestations

  • psychiatric disease manifests itself through behavioral disturbances

Complications

Management

* adjusted hazzard ratios statistically significant, but modest & of unclear clinical significance (Swedish study)

More general terms

More specific terms

Additional terms

References

  1. 1.0 1.1 Lawrence D et al. The gap in life expectancy from preventable physical illness in psychiatric patients in Western Australia: Retrospective analysis of population based registers. BMJ 2013 May 21; 346:f2539. PMID: https://www.ncbi.nlm.nih.gov/pubmed/23694688
  2. Huhn M et al. Efficacy of pharmacotherapy and psychotherapy for adult psychiatric disorders: A systematic overview of meta-analyses. JAMA Psychiatry 2014 Apr 30 <PubMed> PMID: https://www.ncbi.nlm.nih.gov/pubmed/24789675 <Internet> http://archpsyc.jamanetwork.com/article.aspx?articleid=1865002
    Correll CU and Carbon M. Efficacy of pharmacologic and psychotherapeutic interventions in psychiatry: To talk or to prescribe: Is that the question? JAMA Psychiatry 2014 Apr 30 <PubMed> PMID: https://www.ncbi.nlm.nih.gov/pubmed/24789579 <Internet> http://archpsyc.jamanetwork.com/article.aspx?articleid=1865001
  3. Montross C Hard Time or Hospital Treatment? Mental Illness and the Criminal Justice System. N Engl J Med 2016; 375:1407-1409. October 13, 2016 http://www.nejm.org/doi/full/10.1056/NEJMp1606083
  4. 4.0 4.1 Bowling A, Slavet J, Miller DP et al Cybercycling Effects on Classroom Behavior in Children With Behavioral Health Disorders: An RCT. Pediatrics. January 2017 <PubMed> PMID: https://www.ncbi.nlm.nih.gov/pubmed/28069663 <Internet> http://pediatrics.aappublications.org/content/early/2017/01/05/peds.2016-1985
  5. 5.0 5.1 5.2 Hayes JF, Lundin A, Wicks S et al Association of Hydroxylmethyl Glutaryl Coenzyme A Reductase Inhibitors, L-Type Calcium Channel Antagonists, and Biguanides With Rates of Psychiatric Hospitalization and Self-Harm in Individuals With Serious Mental Illness. JAMA Psychiatry. Published online January 9, 2019. PMID: https://www.ncbi.nlm.nih.gov/pubmed/30624557 https://jamanetwork.com/journals/jamapsychiatry/fullarticle/2719703
  6. 6.0 6.1 Plana-Ripoll O, Pedersen CB, Holtz Y et al. Exploring comorbidity within mental disorders among a Danish national population. JAMA Psychiatry 2019 Jan 16; PMID: https://www.ncbi.nlm.nih.gov/pubmed/30649197
    Hyman SE. New evidence for shared risk architecture of mental disorders. JAMA Psychiatry 2019 Jan 16 PMID: https://www.ncbi.nlm.nih.gov/pubmed/30649144